PCSK9 regulates Nox2-mediated platelet activation via CD36 receptor in patients with atrial fibrillation
Background: High levels of proprotein convertase subtilisin/kexin 9 (PCSK9) is predictive of cardiovascular events (CVEs) in atrial fibrillation (AF). We hypothesized that PCSK9 may directly induce platelet activation (PA).